|
SNX16 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.487000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.095400E-03 |
| Normal-vs-Stage2 |
1.555580E-01 |
| Normal-vs-Stage3 |
2.572000E-02 |
| Normal-vs-Stage4 |
4.084300E-02 |
| Stage1-vs-Stage2 |
1.247610E-02 |
| Stage1-vs-Stage3 |
6.816000E-04 |
| Stage1-vs-Stage4 |
9.401700E-03 |
| Stage2-vs-Stage3 |
6.298400E-01 |
| Stage2-vs-Stage4 |
2.872600E-01 |
| Stage3-vs-Stage4 |
4.729800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.062000E-01 |
| Normal-vs-AfricanAmerican |
8.960600E-01 |
| Normal-vs-Asian |
9.760000E-01 |
| Caucasian-vs-AfricanAmerican |
3.541200E-01 |
| Caucasian-vs-Asian |
7.150400E-01 |
| AfricanAmerican-vs-Asian |
9.745200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.461800E-02 |
| Normal-vs-Female |
1.432440E-01 |
| Male-vs-Female |
3.095700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.114000E-01 |
| Normal-vs-Extreme_Weight |
5.082700E-03 |
| Normal-vs-Obese |
6.028800E-01 |
| Normal-vs-Extreme_Obese |
5.754200E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.308090E-02 |
| Normal_Weight-vs-Obese |
7.356400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.044200E-01 |
| Extreme_Weight-vs-Obese |
1.115970E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.769400E-01 |
| Obese-vs-Extreme_Obese |
4.954000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.004450E-01 |
| Normal-vs-Age(41-60Yrs) |
7.596200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.874180E-02 |
| Normal-vs-Age(81-100Yrs) |
1.547750E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.191010E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.084500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.725820E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.336900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.937600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.969400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.677580E-02 |
| Normal-VS-Type2 PRCC |
6.122200E-01 |
| Normal-VS-KIRP CIMP |
8.776300E-03 |
| Normal-VS-Unclassified PRCC |
6.356600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.309600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.802300E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.966400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.50590000000039E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
4.539400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.216370E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.127400E-01 |
| Normal-vs-N1 |
4.876100E-03 |
| Normal-vs-N2 |
2.201700E-02 |
| N0-vs-N1 |
3.540300E-03 |
| N0-vs-N2 |
1.631610E-01 |
| N1-vs-N2 |
6.061400E-01 |
|
|
